“…In Asia, screening programs for common IMD have been carried out in China, India, Japan, Singapore, and Taiwan [Liu and Zuo, 1986;Chen et al, 1989;Rao et al, 1988;Kaur et al, 1994;Tada et al, 1984;Wong, 1978;Hsiao, 1992;Tan et al, 1995]. In the Japanese population, the incidence of maple syrup urine disease (MSUD), phenylketonuria (PKU), and galactosemia are 1/526,000, 1/109,000, and 1/789,000, respectively, the first one similar to, but the last two about ten times lower than in Caucasians [Tada et al, 1984].…”